Summary
Neoplastic cells acquire multidrug resistance as they assemble into multicellular spheroids. Image analysis and Monte Carlo simulation provided an insight into the adhesion and motility events during spheroid restructuring in liquid-overlay culture of DU 145 and LNCaP human prostate cancer cells. Irregularly shaped, two-dimensional aggregates restructured through incremental cell movements into three-dimensional spheroids. Of the two cultures examined, restructuring was more pronounced for DU 145 aggregates. Motile DU 145 cells formed spheroids with a minimum cell overlay of 30% for 25-mers as estimated by simulation versus 5% for adhesive LNCaP cells in aggregates of the same size. Over 72 h, the texture ratio increased from 0.55±0.05 for DU 145 aggregates with projected areas exceeding 2000 μm2 to a value approaching 0.75±0.02 (P<0.05). For LNCaP aggregates of comparable size, the increase in texture ratio was more modest, less than 15% during the same time period (P<0.05). Combined, these data suggest that motility events govern the overall rate of spheroid restructuring. This information has application to the chemosensitization of solid tumors and kinetic modeling of spheroid production.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allen, M. P.; Tildesley, D. J. Computer simulation of liquids. New York: Oxford University Press; 2002:118–121.
Bauerschmitz, G. J.; Lam, J. T.; Kanerva, A., et al. Treatment of ovarian cancer with a tropism modified oncolytic adenovirus. Cancer Res. 62:1266–1270; 2002.
Desoize, B.; Gimonet, D.; Jardiller, J.-C., Cell culture as spheroids: an approach to multicellular resistance. Anticancer Res. 18:4147–4158; 1998.
Enmon, R. M.; O'Connor, K. C.; Lacks, D. J.; Schwartz, D. K.; Dotson, R. S. Dynamics of spheroid self-assembly in liquid-overlay cultures of DU 145 human prostate cancer cells. Biotechnol. Bioeng. 72:579–591; 2001.
Enmon, R. M.; O'Connor, K. C.; Song, H.; Lacks D. J.; Schwartz, D. K. Aggregation kinetics of well and poorly differentiated human prostate cancer cells. Biotechnol. Bioeng. 80:580–588; 2002.
Francescon, P.; Cora, S.; Chiovati, P. Dose verification of an IMRT treatment planning system with the BEAM EGS4-based Monte Carlo code. Med. Phys. 30:144–157; 2003.
Goel, N. S.; Rogers, G.. Computer simulation of engulfment and other movements of embryonic tissues. J. Theor. Biol. 71:103–140; 1978.
Hoosein, N. M.; Boyd, D. D.; Hollas, W. J.; Mazar, A.; Henkin, J.; Chung, L. W. Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines. Cancer Commun. 3:255–264; 1991.
Jemal, A.; Murray, T.; Samuels, A.; Ghafoor, A.; Ward, E.; Thun, M. J. Cancer statistics, 2003, CA Cancer J. Clin. 53:5–26; 2003.
Kitahara, M.; Katakura, R.; Suzuki, J.; Sasaki, T. Experimental combination chemotherapy of ACNU and 5-FU against cultured glioma model (spheroid) and subcutaneous rat glioma. Int. J. Cancer 40:557–563; 1987.
Lelkes, P. I.; Ramos, E.; Nikolaychik, V. V.; Wankowski, D. M.; Unsworth, B. R.; Goodwin, T. J. GTSF-2: a new, versatile cell culture medium for diverse normal and transformed mammalian cells. In Vitro Cell. Dev. Biol. 33A:344–451; 1997.
Liebovitch, L. S. Fractals and chaos simplified for the life sciences, New York: Oxford University Press; 1998:46–59.
Meakin, P. Diffusion-controlled aggregation on two-dimensional square lattices: results from a new cluster-cluster aggregation model. Phys. Rev. B 29:2930–2942; 1984.
Meakin, P. The effects of random bond breaking on diffusion limited cluster-cluster aggregation. J. Chem. Phys. 83:3645–3649; 1985.
Meakin, P.; Jullien, R. Structural readjustment effects in cluster-cluster aggregation. J. Physique 46:1543–1552; 1985.
Moore, G. W.; Berman, J. J. Cell growth simulations predicting polyclonal origins for ‘monoclonal’ tumors. Cancer Lett. 60:113–119; 1991.
O'Connor, K. C. Three-dimensional cultures of prostatic cells: tissue models for the development of novel anti-cancer therapies. Pharm. Res. 16:486–493; 1999.
Persson, A.-L. Image analysis of shape and size of fine aggregates. Eng. Geol. 50:177–186; 1998.
Sagvolden, G.; Giaever, I.; Pettersen, E. O.; Felder, J. Cell adhesion force microscopy. Proc. Natl. Acad. Sci. USA 96:471–476; 1999.
Saxton, M. J. Lateral diffusion and aggregation: a Monte Carlo study. Biophy. J. 61:119–128; 1992.
Sokoloff, M. H.; Tso, C.-L.; Kaboo, R.; Taneja, S.; Pang, S.; de Kernion, J. B.; Belldegrun, A. S. In vitro modulation of tumor progression-associated properties of hormone refractory prostate cancer cell lines by cytokines. Cancer 77:1862–1872; 1996.
Song, H.; O'Connor, K. C.; Lacks, D. J.; Enmon, R. M.; Jain, S. K. Monte Carlo simulation of LNCaP human prostate cancer cell aggregation in liquid-overlay culture. Biotechnol. Prog. 19:1742–1749; 2003.
Song, H.; O'Connor, K. C.; Papadopoulos, K. D.; Jansen, D. A. Differentiation kinetics of in vitro 3T3-L1 preadipocyte cultures. Tissue Eng. 8:1071–1081; 2002.
Spruss, T.; Bernhardt, G.; Schonenberger, H.; Schiess, W. Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma. J. Cancer Res. Clin. Oncol. 121:193–202; 1995.
St. Croix, B.; Rak, J. W.; Kapitain, S.; Sheehan, C.; Graham, C. H.; Kerbel, R. S. Reversal by hyaluronidase of adhesion-dependent multicellular drug resistance in mammary carcinoma cells. J. Natl. Cancer Inst. 88:1285–1296; 1996.
Sternberg, C. N. What's new in the treatment of advanced prostate cancer? Eur. J. Cancer 39:136–146; 2003.
van Brussel, J.; van Steenbrugge, G. J.; van Krimpen, C.; Bogdanowicz, J. F. A. T.; van der Kwast, T. H.; Schröder, F. H.; Mickisch, G. H. Expression of multidrug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer. J. Urol. 165:130–135; 2001.
Wartenberg, M.; Frey, C.; Diedershagen, H.; Rigen, J.; Hescheler, J.; Sauer, H. Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids. Int. J. Cancer 75:855–863; 1998.
Yu, E. Y.; Oh, W. K. Neoadjuvant therapy for high-risk localized prostate cancer. Curr. Oncol. Rep. 5:250–257; 2003.
Yuhas, J. M.; Li, A. P.; Martinez, A. O.; Ladman, A. J. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res. 37:3639–3643; 1977.
Zhorov, B. S.; Lin, S. X. Monte Carlo-minimized energy profile of estradiol in the ligand-binding tunnel of 17 beta-hydroxysteroid dehydrogenase: atomic mechanisms of steroid recognition. Proteins 38:414–427; 2000.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Song, H., Jain, S.K., Enmon, R.M. et al. Restructuring dynamics of du 145 and LNCaP prostate cancer spheroids. In Vitro Cell.Dev.Biol.-Animal 40, 262–267 (2004). https://doi.org/10.1290/0406038.1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1290/0406038.1